Elacridar
Elacridar is a P-glycoprotein inhibitor, and has been used both in vitro and in vivo as a tool inhibitor of P-glycoprotein (Pgp) to investigate the role of transporters in the disposition of various test molecules.
| Trivial name | GW-120918; GW-0918 |
| Catalog Number | CSN10894 |
| Alternative Name(s) | GW-120918; GW-0918 |
| Research Area | Cancer |
| Molecular Formula | C34H33N3O5 |
| CAS# | 143664-11-3 |
| Purity | ≥99% |
| SMILES | O=C(C(C=CC=C1C2=O)=C1NC3=C2C=CC=C3OC)NC4=CC=C(CCN5CC6=C(C=C(OC)C(OC)=C6)CC5)C=C4 |
| Size | 5mg |
| Supplier Page | https://www.csnpharm.com/products/elacridar.html |